Amount$100M
Post-money valuation$6.1B
SeriesSeries F
AnnouncedNov 17, 2021
SectorBIO + LIFE SCIENCES
Strong
A strong, well-structured round.
Round size vs peers
In line with the typical Series F round.
Syndicate size
Healthy syndicate of 4 investors.
Insider conviction
2 existing investors re-upped — insiders doubling down.
Investor track record
Mostly newer or unproven managers.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series F rounds (255)
Round size distribution37th pct
smaller Series F roundslarger
Post-money valuation72th pct
$200Mthis round: $6.1B$15B
vs. BIO + LIFE SCIENCES (25)
Round size in sector88th pct
$300Kthis round: $100M$100M
